Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Environ Mol Mutagen ; 58(1): 4-18, 2017 01.
Article in English | MEDLINE | ID: mdl-28079927

ABSTRACT

Epidemiologic studies and studies in rodents point to potential risks from developmental exposure to BPA on cardiometabolic diseases. Furthermore, it is becoming increasingly evident that the manifestation and severity of adverse outcomes is the result of interaction between developmental insults and the prevailing environment. Consistent with this premise, recent studies in sheep found prenatal BPA treatment prevented the adverse effects of postnatal obesity in inducing hypertension. The gene networks underlying these complex interactions are not known. mRNA-seq of myocardium was performed on four groups of four female sheep to assess the effects of prenatal BPA exposure, postnatal overfeeding and their interaction on gene transcription, pathway perturbations and functional effects. The effects of prenatal exposure to BPA, postnatal overfeeding, and prenatal BPA with postnatal overfeeding all resulted in transcriptional changes (85-141 significant differentially expressed genes). Although the effects of prenatal BPA and postnatal overfeeding did not involve dysregulation of many of the same genes, they affected a remarkably similar set of biological pathways. Furthermore, an additive or synergistic effect was not found in the combined treatment group, but rather prenatal BPA treatment led to a partial reversal of the effects of overfeeding alone. Many genes previously known to be affected by BPA and involved in obesity, hypertension, or heart disease were altered following these treatments, and AP-1, EGR1, and EGFR were key hubs affected by BPA and/or overfeeding. Environ. Mol. Mutagen. 58:4-18, 2017. © 2016 Wiley Periodicals, Inc.


Subject(s)
Benzhydryl Compounds/toxicity , Endocrine Disruptors/toxicity , Fetal Development/drug effects , Myocardium/metabolism , Obesity/chemically induced , Phenols/toxicity , Prenatal Exposure Delayed Effects/chemically induced , Transcriptome/drug effects , Animal Feed , Animals , Birth Weight/drug effects , Body Weight/drug effects , Female , Fetal Development/genetics , Gene Expression Profiling , Gene-Environment Interaction , Gestational Age , Obesity/genetics , Obesity/metabolism , Pregnancy , Prenatal Exposure Delayed Effects/genetics , Prenatal Exposure Delayed Effects/metabolism , Sheep
2.
Hum Reprod ; 22(5): 1247-52, 2007 May.
Article in English | MEDLINE | ID: mdl-17293344

ABSTRACT

BACKGROUND: This study seeks to clarify cell cycle dynamics of granulosa cells following hCG and elucidate the expression of epidermal growth factor (EGF)-like ligands during luteinization. METHODS: Granulosa cells were obtained from rhesus macaques undergoing controlled ovarian stimulation protocols before or after an ovulatory hCG bolus. Cell cycle characteristics were determined by flow cytometry and levels of EGF receptor (EGFR), amphiregulin (AREG), epiregulin (EREG) and betacellulin (BTC) mRNAs were measured by real-time RT-PCR. RESULTS: The proportion of cells in S-phase was 7.5% prior to hCG and did not decline until 24 h after hCG (3.1%). EGFR protein and BTC mRNA did not change following hCG, whereas AREG and EREG mRNA increased starting at 3 and 12 h post-hCG, respectively, and remained elevated thereafter. CONCLUSIONS: Cell cycle transit of macaque granulosa cells does not change until 24 h after an ovulatory stimulus, whereas the EGF-like ligands EREG and AREG are increased rapidly. This suggests that luteinizing granulosa cells are refractory to mitogenic stimulation by EGFR ligands.


Subject(s)
Cell Proliferation/drug effects , Epidermal Growth Factor/metabolism , ErbB Receptors/metabolism , Glycoproteins/metabolism , Granulosa Cells/physiology , Intercellular Signaling Peptides and Proteins/metabolism , Ovulation/metabolism , Amphiregulin , Animals , Betacellulin , Cell Cycle/drug effects , Chorionic Gonadotropin/pharmacology , Epiregulin , Female , Flow Cytometry , Gene Expression Regulation/drug effects , Granulosa Cells/drug effects , Luteal Phase/metabolism , Macaca mulatta , Ovulation Induction/methods , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...